| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 药品制剂(元) | - | 1,515,167,497.87 | - | 1,450,792,021.48 |
| 医疗器械(元) | 233,400,261.36 | 115,970,065.24 | 198,000,059.02 | 94,647,044.90 |
| 分部间抵销(元) | - | -1,328,857.17 | - | -2,194,682.21 |
| 妇科用药(元) | 84,070,373.83 | - | 143,629,089.38 | - |
| 精神神经系统类(元) | 138,768,292.17 | - | 146,244,634.38 | - |
| 慢性肾病类(元) | 388,459,394.44 | - | 377,465,421.10 | - |
| 皮肤病类(元) | 382,765,569.85 | - | 307,323,536.48 | - |
| 糖尿病类(元) | 418,443,893.53 | - | 418,749,304.77 | - |
| 消化系统类(元) | 438,454,579.22 | - | 377,205,982.17 | - |
| 心血管类(元) | 940,815,337.79 | - | 1,047,273,778.08 | - |
| 其他(元) | 3,053,330.80 | - | 8,349,170.41 | - |
| 其他药品制剂(元) | - | - | 212,767,924.26 | - |
| 其他治疗领域(元) | 299,432,244.80 | - | - | - |
| 营业成本(元) | ||||
| 药品制剂(元) | - | 457,679,023.01 | - | 401,495,602.15 |
| 医疗器械(元) | 124,912,618.81 | 64,264,957.04 | 109,095,155.15 | 87,032,989.67 |
| 分部间抵销(元) | - | -1,328,857.17 | - | -2,194,682.21 |
| 妇科用药(元) | 27,560,871.27 | - | 42,837,212.51 | - |
| 精神神经系统类(元) | 23,307,653.81 | - | 23,129,516.28 | - |
| 慢性肾病类(元) | 152,799,144.66 | - | 119,123,734.02 | - |
| 皮肤病类(元) | 182,839,009.15 | - | 156,830,083.38 | - |
| 糖尿病类(元) | 65,538,408.35 | - | 79,832,830.78 | - |
| 消化系统类(元) | 217,759,975.56 | - | 216,771,723.01 | - |
| 心血管类(元) | 154,834,913.53 | - | 162,380,697.69 | - |
| 其他(元) | 4,401,020.91 | - | 5,668,594.68 | - |
| 其他药品制剂(元) | - | - | 112,359,658.17 | - |
| 其他治疗领域(元) | 153,794,872.53 | - | - | - |
| 毛利(元) | ||||
| 药品制剂(元) | - | 1,057,488,474.86 | - | 1,049,296,419.33 |
| 医疗器械(元) | 108,487,642.55 | 51,705,108.20 | 88,904,903.87 | 7,614,055.23 |
| 分部间抵销(元) | - | - | - | - |
| 妇科用药(元) | 56,509,502.56 | - | 100,791,876.87 | - |
| 精神神经系统类(元) | 115,460,638.36 | - | 123,115,118.10 | - |
| 慢性肾病类(元) | 235,660,249.78 | - | 258,341,687.08 | - |
| 皮肤病类(元) | 199,926,560.70 | - | 150,493,453.10 | - |
| 糖尿病类(元) | 352,905,485.18 | - | 338,916,473.99 | - |
| 消化系统类(元) | 220,694,603.66 | - | 160,434,259.16 | - |
| 心血管类(元) | 785,980,424.26 | - | 884,893,080.39 | - |
| 其他(元) | -1,347,690.11 | - | 2,680,575.73 | - |
| 其他药品制剂(元) | - | - | 100,408,266.09 | - |
| 其他治疗领域(元) | 145,637,372.27 | - | - | - |
| 毛利率(%) | ||||
| 药品制剂(%) | - | 69.79 | - | 72.33 |
| 医疗器械(%) | 46.48 | 44.58 | 44.90 | 8.04 |
| 分部间抵销(%) | - | - | - | - |
| 妇科用药(%) | 67.22 | - | 70.18 | - |
| 精神神经系统类(%) | 83.20 | - | 84.18 | - |
| 慢性肾病类(%) | 60.67 | - | 68.44 | - |
| 皮肤病类(%) | 52.23 | - | 48.97 | - |
| 糖尿病类(%) | 84.34 | - | 80.94 | - |
| 消化系统类(%) | 50.33 | - | 42.53 | - |
| 心血管类(%) | 83.54 | - | 84.49 | - |
| 其他(%) | -44.14 | - | 32.11 | - |
| 其他药品制剂(%) | - | - | 47.19 | - |
| 其他治疗领域(%) | 48.64 | - | - | - |
| 收入构成(%) | ||||
| 药品制剂(%) | - | 92.97 | - | 94.01 |
| 医疗器械(%) | 7.01 | 7.12 | 6.12 | 6.13 |
| 分部间抵销(%) | - | -0.08 | - | -0.14 |
| 妇科用药(%) | 2.53 | - | 4.44 | - |
| 精神神经系统类(%) | 4.17 | - | 4.52 | - |
| 慢性肾病类(%) | 11.67 | - | 11.66 | - |
| 皮肤病类(%) | 11.50 | - | 9.49 | - |
| 糖尿病类(%) | 12.57 | - | 12.94 | - |
| 消化系统类(%) | 13.18 | - | 11.65 | - |
| 心血管类(%) | 28.27 | - | 32.35 | - |
| 其他(%) | 0.09 | - | 0.26 | - |
| 其他药品制剂(%) | - | - | 6.57 | - |
| 其他治疗领域(%) | 9.00 | - | - | - |
| 毛利构成(%) | ||||
| 药品制剂(%) | - | 95.34 | - | 99.28 |
| 医疗器械(%) | 4.89 | 4.66 | 4.02 | 0.72 |
| 分部间抵销(%) | - | 0.00 | - | 0.00 |
| 妇科用药(%) | 2.55 | - | 4.56 | - |
| 精神神经系统类(%) | 5.20 | - | 5.57 | - |
| 慢性肾病类(%) | 10.62 | - | 11.70 | - |
| 皮肤病类(%) | 9.01 | - | 6.81 | - |
| 糖尿病类(%) | 15.90 | - | 15.34 | - |
| 消化系统类(%) | 9.94 | - | 7.26 | - |
| 心血管类(%) | 35.41 | - | 40.06 | - |
| 其他(%) | -0.06 | - | 0.12 | - |
| 其他药品制剂(%) | - | - | 4.55 | - |
| 其他治疗领域(%) | 6.56 | - | - | - |